JSPR - Jasper Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JSPR is currently covered by 7 analysts with an average price target of $27.05. This is a potential upside of $23.72 (712.31%) from yesterday's end of day stock price of $3.33.

Jasper Therapeutics's activity chart (see below) currently has 22 price targets and 48 ratings on display. The stock rating distribution of JSPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 1.79% with an average time for these price targets to be met of 56.63 days.

Highest price target for JSPR is $65, Lowest price target is $5, average price target is $27.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 08-Jul-2025. First documented stock forecast 14-Oct-2021.

Currently out of the existing stock ratings of JSPR, 29 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$8.67 (260.36%)

11 days ago
(08-Jul-2025)

0/5 (0%)

$8.98 (297.35%)

Buy

$5

$1.67 (50.15%)

11 days ago
(08-Jul-2025)

0/4 (0%)

$1.98 (65.56%)

Buy

$20

$16.67 (500.60%)

$40

12 days ago
(07-Jul-2025)

0/9 (0%)

$16.96 (557.89%)

Buy

$20

$16.67 (500.60%)

12 days ago
(07-Jul-2025)

0/2 (0%)

$16.96 (557.89%)

Buy

$65

$61.67 (1851.95%)

$80

2 months 4 days ago
(15-May-2025)

0/3 (0%)

$60.13 (1234.70%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JSPR (Jasper Therapeutics) average time for price targets to be met?

On average it took 56.63 days on average for the stock forecasts to be realized with a an average price target met ratio 1.79

Which analyst has the current highest performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on JSPR (Jasper Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 7 price targets and 5 ratings on JSPR

Which analyst is the currently most bullish on JSPR (Jasper Therapeutics)?

Michael King with highest potential upside - $65.17

Which analyst is the currently most reserved on JSPR (Jasper Therapeutics)?

Gregory Renza with lowest potential downside - $1.67

Jasper Therapeutics in the News

Jasper Therapeutics stock downgraded by BMO Capital on CSU trial concerns

Investing.com – BMO Capital downgraded Jasper Therapeutics (NASDAQ:JSPR) from Outperform to Market Perform on Monday, while maintaining a price target of $4.00. The stock, currently trading at $3.04, has experienced significant volatility, with a -68% year-to-date return despite showing strong momentum in recent weeks. According to InvestingPro data, the overall analyst consensus remains bullish at...

Jasper Therapeutics stock price target lowered to $20 by Evercore ISI

Investing.com – Evercore ISI reduced its price target on Jasper Therapeutics (NASDAQ:JSPR) to $20.00 from $50.00 on Monday, while maintaining an Outperform rating on the stock. The company’s shares, currently trading at $3.04, have shown significant volatility with a 22% gain over the past week, according to InvestingPro data. The firm’s analyst cited expectations that...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?